Skip to main content
. Author manuscript; available in PMC: 2014 Aug 25.
Published in final edited form as: Procedia Vaccinol. 2014 Jan 1;8:38–42. doi: 10.1016/j.provac.2014.07.007

Figure 2. Experimental design to evaluate BpsOMV vaccine safety and immunogenicity in rhesus macaques.

Figure 2

Animals were immunized with escalating doses of Bps OMVs admixed with CpG ODN (n=2) or CpG ODN alone (n=2).